东方精工:2023年第一季度报告(英文)
GUANGDONG DONGFANG PRECISION SCIENCE & TECHNOLOGY CO., LTD.
THE REPORT FOR THE FIRST QUARTER OF 2023
The Company as well as all members of the Board of Directors hereby guarantee thefactuality, accuracy, and completeness of the information disclosed, and its free of anymisrepresentations, misleading statements, or material omissions.
Important Notes:
1. The Board of Directors (or the “Board”), the Supervisory Committee as well as the directors,supervisors and senior management of Guangdong Dongfang Precision Science & Technology Co., Ltd.(hereinafter referred to as the “Company”) hereby guarantee the factuality, accuracy, and completeness of thecontents of this Report, and shall be jointly and severally liable for any misrepresentations, misleadingstatements, or material omissions therein.
2. The Company’s legal representative, the Company’s Chief Financial Officer, and the person-in-chargeof the accounting organ hereby guarantee that the financial statements carried in this Report are factual,accurate and complete.
3. Whether the 1
stquarter report has been audited
□ Yes √ No
The report for the 1
stquarter of 2023 of the Company has been prepared and released in Chinese,and now has been translated into English. Should there be any discrepancies or misunderstandingsbetween the two versions, the Chinese version shall prevail.
I Key Financial Information
1. Key Financial Data and Indicators
Indicate whether there is any retrospectively restated datum in the table below.
□ Yes √ No
Q1 2023 | Q1 2022 | Rate of Change | |
Operating revenue (RMB) | 907,101,141.80 | 636,006,580.11 | 42.62% |
Net profit attributable to the listed company’s shareholders (RMB yuan) | 84,973,342.92 | 37,109,411.15 | 128.98% |
Net profit attributable to the listed company’s shareholders before exceptional gains and losses (RMB yuan) | 51,961,918.89 | 45,662,017.31 | 13.80% |
Net cash generated from/used in operating activities (RMB yuan) | 104,429,591.30 | 85,523,348.92 | 22.11% |
Basic earnings per share (RMB / share) | 0.07 | 0.03 | 133.33% |
Diluted earnings per share (RMB /share) | 0.07 | 0.03 | 133.33% |
Weighted average return on equity (ROE) | 2.08% | 1.02% | 1.06% |
Ending balance Of the Reporting Period | Beginning balance Of the Reporting Period | Rate of Change | |
Total assets (RMB) | 7,127,787,958.35 | 6,928,577,115.10 | 2.88% |
Equity attributable to the listed company’s shareholders (RMB) | 4,096,865,613.57 | 4,063,966,310.23 | 0.81% |
2. Non-recurring profit and loss items and amount
√ Applicable □ Not applicable
Unit: RMB
Item | Q1 2023 | Notes |
Gain or loss on disposal of non-current assets (inclusive of impairment allowance write-offs) | -382,067.42 | |
Government subsidies included in current profit or loss (exclusive of government grants given in the Company’s ordinary course of business at fixed quotas or amounts as per the government’s uniform standards) | 2,550,704.06 | |
Gain or loss on fair-value changes on held-for-trading and derivative financial assets and liabilities & income from disposal of held-for-trading and derivative financial assets and liabilities and other debt investments (exclusive of the effective portion of hedges that arise in the Company’s ordinary course of business) | 32,150,522.32 | |
Non-Operating Revenue and expenses other than the above | -6,857.27 | |
Less: Income tax effects | 229,557.37 | |
Non-controlling interests effects (net of tax) | 1,071,320.29 | |
Total | 33,011,424.03 | -- |
Other items that meet the definition of non-recurring profit and loss:
□ Applicable √ Not applicable
No such cases for the Reporting Period.
Note of the reclassification of non-recurring items of profit or loss listed in "Explanatory Announcement No. 1 on Disclosure ofInformation by Companies Issuing Public Securities - Non-recurring Profit or Loss" as recurring items of profit or loss:
□ Applicable √ Not applicable
No such cases for the Reporting Period.
Guangdong Dongfang Precision Science & Technology Co., Ltd. Report of Q1 2023
3. Changes in Key Financial Data and Indicators and the Reasons
√Applicable □ Not applicable
Unit: RMB
(1) Balance sheet items
Items | Ending balance Of the Reporting Period | Beginning balance Of the Reporting Period | Amount of Change | Rate of Change | Notes |
Cash and bank balances | 1,429,733,808.80 | 1,274,447,199.74 | 155,286,609.06 | 12.18% | Mainly due to the increase of amount received for sales and the redemption of some entrusted wealth management products during the reporting period. |
Financial assets held for trading | 826,564,639.52 | 860,832,278.88 | -34,267,639.36 | -3.98% | Mainly due to the redemption of some entrusted wealth management products during the reporting period. |
Accounts receivable | 765,635,440.37 | 837,305,757.46 | -71,670,317.09 | -8.56% | Mainly due to the increase of amount received for sales in the reporting period. |
Other receivables | 38,754,459.26 | 83,996,902.82 | -45,242,443.56 | -53.86% | Mainly due to the early recovery of the remaining balance of the transfer of equity interest of the Ferretto Group during the reporting period. |
Inventories
Inventories | 1,241,618,636.81 | 1,092,981,884.51 | 148,636,752.30 | 13.60% | Mainly due to the increase in orders and the increase in inventories during the reporting period. |
Construction in progress | 71,640,546.10 | 38,904,537.85 | 32,736,008.25 | 84.14% | Mainly due to the investment in the construction of plants during the reporting period. |
Short-term borrowings | 96,301,680.12 | 41,815,129.24 | 54,486,550.88 | 130.30% | Mainly due to the increase in borrowings during the reporting period. |
Accounts payable | 703,414,660.38 | 748,319,561.21 | -44,904,900.83 | -6.00% | Mainly due to the payment for goods during the reporting period. |
Contract liabilities | 825,114,775.47 | 692,567,968.60 | 132,546,806.87 | 19.14% | Mainly due to the increase in orders during the reporting period. |
Treasury stock | 309,451,578.83 | 240,255,502.45 | 69,196,076.38 | 28.80% | Mainly due to share repurchase during the reporting period. |
(2) Income statement items
Items | Q1 2023 | Q1 2022 | Amount of Change | Rate of Change | Notes |
Operating revenue | 907,101,141.80 | 636,006,580.11 | 271,094,561.69 | 42.62% | Mainly due to the increase in sales during the reporting period. |
Guangdong Dongfang Precision Science & Technology Co., Ltd. Report of Q1 2023
Cost of sales | 653,454,327.84 | 472,346,527.10 | 181,107,800.74 | 38.34% | Mainly due to the increase in sales for the reporting period. |
Selling expenses | 49,395,917.66 | 24,373,541.29 | 25,022,376.37 | 102.66% | Mainly due to the increase in sales during the reporting period. |
R&D expenses | 27,637,218.09 | 18,824,950.19 | 8,812,267.90 | 46.81% | Mainly due to increased investment in research and development during the reporting period. |
Finance costs | 4,922,184.62 | -5,516,912.35 | 10,439,096.97 | 189.22% | Mainly due to changes in exchange rates during the reporting period. |
Investment income | 11,843,626.19 | -4,249,447.63 | 16,093,073.82 | 378.71% | Mainly due to the increase in investment income recognized from the implementation of investments in securities during the reporting period. |
Gain/loss on changes in fair value | 18,689,791.21 | -8,257,489.80 | 26,947,281.01 | 326.34% | Mainly due to the increase in fair value changes recognized on the implementation of investments in securities during the reporting period. |
(3) Cash flow statement items
Items | Q1 2023 | Q1 2022 | Amount of Change | Rate of Change | Notes |
Net cash generated from/used in operating activities | 104,429,591.30 | 85,523,348.92 | 18,906,242.38 | 22.11% | Mainly due to the increase in sales returns for the period. |
Net cash generated from/used in investing activities | 72,757,007.84 | -2,853,044.36 | 75,610,052.20 | 2650.15% | Mainly due to investment in subsidiaries in the same period last year, which did not occur in the current period. |
Net cash generated from/used in financing activities | -42,170,254.94 | 19,572,369.24 | -61,742,624.18 | -315.46% | Mainly due to the recovery of loan deposits in the previous year, which did not occur in the current period. |
II Shareholder Information
1. Total Number of Ordinary Shareholders and Number of Preference Shareholders with Resumed VotingRights, as well as Information of Top 10 Shareholders
Unit: shares
Number of ordinary shareholders at the period-end | 59,477 | Number of preference shareholders with resumed voting rights at the period-end (if any) | Not applicable | |||||
Top 10 shareholders | ||||||||
Name of shareholder | Nature of shareholder | Shareholding percentage | Total shares held at the period-end | Restricted shares held | Shares in pledge or frozen | |||
Status | Shares | |||||||
Tang Zhuolin | Domestic individual | 21.82% | 270,737,568 | 203,053,176 | In pledge | 105,360,000 | ||
Tang Zhuomian | Domestic individual | 7.81% | 96,885,134 | 0 | In pledge | 40,000,000 | ||
Pulead Technology Industry Co., Ltd. | State-owned corporation | 3.88% | 48,149,787 | 0 | ||||
Luzhou Industrial Development Investment Group Co., Ltd. | State-owned corporation | 2.56% | 31,770,010 | 0 | ||||
Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) | Domestic non-state-owned corporation | 2.15% | 26,628,340 | 0 | ||||
Qiu Yezhi | Domestic individual | 1.88% | 23,382,388 | 23,382,388 | ||||
Hong Kong Securities Clearing Company Limited | Overseas corporation | 1.27% | 15,712,884 | 0 | ||||
JIC Investment Co., Ltd. | State-owned corporation | 0.72% | 8,884,216 | 0 | ||||
Shengji Equity Investment Fund (Shanghai) Co., Ltd. | State-owned corporation | 0.58% | 7,198,000 | 0 | In pledge | 6,700,000 | ||
Liu Wucai | Domestic individual | 0.53% | 6,597,688 | 0 | ||||
Top 10 unrestricted ordinary shareholders | ||||||||
Name of shareholder | Unrestricted shares held at the period-end | Shares by type | ||||||
Type | Shares | |||||||
Tang Zhuomian | 96,885,134 | RMB ordinary shares | 96,885,134 | |||||
Tang Zhuolin | 67,684,392 | RMB ordinary shares | 67,684,392 | |||||
Pulead Technology Industry Co., Ltd. | 48,149,787 | RMB ordinary shares | 48,149,787 | |||||
Luzhou Industrial Development Investment Group Co., Ltd. | 31,770,010 | RMB ordinary shares | 31,770,010 | |||||
Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) | 26,628,340 | RMB ordinary shares | 26,628,340 |
Hong Kong Securities Clearing Company Limited | 15,712,884 | RMB ordinary shares | 15,712,884 |
JIC Investment Co., Ltd. | 8,884,216 | RMB ordinary shares | 8,884,216 |
Shengji Equity Investment Fund (Shanghai) Co., Ltd. | 7,198,000 | RMB ordinary shares | 7,198,000 |
Liu Wucai | 6,597,688 | RMB ordinary shares | 6,597,688 |
Beixin Ruifeng Fund - ICBC - Beijing Hengyutianze Investment Management Co. | 6,171,777 | RMB ordinary shares | 6,171,777 |
Related or acting-in-concert parties among the shareholders above | Tang Zhuolin and Tang Zhuomian are full brothers. On 18 August 2010, they signed the Agreement on Acting in Concert. Pulead Technology Industry Co., Ltd., and Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) are acting-in-concert parties. Except for these, the Company does not know whether the other shareholders are related parties or whether they are acting-in-concert parties in accordance with the Measures for the Administration of acquisitions of listed companies. | ||
Note on the top 10 shareholders' participation in securities margin trading (if any) | As of 31 March 2023, Pulead Technology Industry Co., Ltd., held 48,149,665 shares through the credit securities account. And Luzhou Industrial Development Investment Group Co., Ltd., held 31,770,010 shares through the credit securities account, as well as Qinghai Puren Intelligent Technology R & D Center (Limited Partnership) held 26,628,300 shares through the credit securities account. |
Explanation on the shareholding of the repurchase accountAs of the end of the Reporting Period, there were 36,424,192 shares in the Company’s special account for repurchase, accounting for
2.94% of its total share capital. As per the Shenzhen Stock Exchange Guideline No. 1 for the Self-regulation of Listed Companies—Business Handling, the existence of a special account of repurchased shares among the top 10 shareholders should be specifically statedbut not included in the presentation of the top 10 shareholders.
2. Total Number of Preference Shareholders and Information of Top 10 Preference Shareholders
□ Applicable √ Not applicable
III Other Significant Events
□Applicable √ Not applicable
IV Quarterly Financial Statements
1. Financial Statements
(1) Consolidated Balance Sheet
Prepared by: Guangdong Dongfang Precision Science & Technology Co., Ltd.
31 March 2023
Unit: RMB
Item | 31 March 2023 | 1 January 2023 |
Current assets: | ||
Cash and bank balances | 1,429,733,808.80 | 1,274,447,199.74 |
Settlement provisions |
Item | 31 March 2023 | 1 January 2023 |
Dismantling funds | ||
Financial assets held for trading | 826,564,639.52 | 860,832,278.88 |
Derivative financial assets | ||
Notes receivable | 25,771,245.44 | 24,566,100.12 |
Accounts receivable | 765,635,440.37 | 837,305,757.46 |
Receivable financing | 22,932,959.13 | 15,305,668.26 |
Prepayments | 68,792,086.54 | 64,946,901.26 |
Premium receivable | ||
Receivable reinsurance account | ||
Provision for reinsurance contract receivable | ||
Other receivables | 38,754,459.26 | 83,996,902.82 |
Including: Interest receivable | ||
Dividend receivable | ||
Buy back resale financial assets | ||
Inventories | 1,241,618,636.81 | 1,092,981,884.51 |
Contract assets | 49,349,058.58 | 65,089,851.21 |
Assets held for sale | ||
Current portion of non-current assets | 314,157,500.00 | 311,763,750.00 |
Other current assets | 69,839,768.49 | 61,370,451.31 |
Total current assets | 4,853,149,602.94 | 4,692,606,745.57 |
Non-current assets: | ||
Loans and advances | ||
Debt investment | ||
Other debt investments | ||
Long-term receivables | 964,299.00 | 1,294,299.00 |
Long-term equity investment | 93,752,046.01 | 95,352,681.52 |
Investment in other equity instruments | ||
Other non-current financial assets | 334,959,677.33 | 334,449,603.33 |
Real estate investment | ||
Fixed assets | 565,867,646.04 | 570,200,113.79 |
Construction in progress | 71,640,546.10 | 38,904,537.85 |
Productive biological assets | ||
Oil and gas asset | ||
Right-of-use assets | 84,141,310.80 | 86,448,978.02 |
Intangible assets | 363,731,709.22 | 368,103,395.11 |
Development expenditure | 3,702,229.76 | 3,702,229.76 |
Goodwill | 432,511,475.32 | 430,916,848.74 |
Long-term prepaid expenses | 18,420,319.96 | 16,735,552.98 |
Item | 31 March 2023 | 1 January 2023 |
Deferred tax assets | 247,119,485.63 | 244,542,124.61 |
Other non-current assets | 57,827,610.24 | 45,320,004.82 |
Total non-current assets | 2,274,638,355.41 | 2,235,970,369.53 |
Total assets | 7,127,787,958.35 | 6,928,577,115.10 |
Current liabilities: | ||
Short-term borrowings | 96,301,680.12 | 41,815,129.24 |
Borrowing from the Central Bank | ||
Borrowed funds | ||
Financial liabilities held for trading | 57,027,528.33 | 57,022,555.58 |
Derivative financial liabilities | ||
Notes payable | 130,127,953.80 | 149,918,253.31 |
Accounts payable | 703,414,660.38 | 748,319,561.21 |
Advance receivables | ||
Contract liabilities | 825,114,775.47 | 692,567,968.60 |
Selling back financial assets | ||
Deposits and Interbank deposit | ||
Agent trading securities | ||
Agent underwriting securities | ||
Employee benefits payable | 126,518,352.61 | 123,695,328.31 |
Tax payable | 34,356,429.92 | 24,111,703.70 |
Other payables | 114,071,613.11 | 90,080,142.50 |
Including: Interest payable | ||
Dividend payable | ||
Fees and commissions | ||
Reinsurance accounts payable | ||
Liabilities held for sale | ||
Current portion of non-current liabilities | 320,259,921.59 | 315,767,431.26 |
Other current liabilities | 7,843,151.62 | 5,988,879.29 |
Total current liabilities | 2,415,036,066.95 | 2,249,286,953.00 |
Non-current liabilities: | ||
Insurance contract reserve | ||
Long-term borrowings | 56,452,115.15 | 57,884,494.89 |
Bonds payable | ||
Including: Preference Shares | ||
Perpetual bonds | ||
Lease liabilities | 61,528,268.38 | 68,989,111.33 |
Long-term payables | ||
Long-term employee benefits payable | 12,896,110.14 | 13,179,944.17 |
Provisions | 118,690,395.19 | 118,945,953.78 |
Item | 31 March 2023 | 1 January 2023 |
Deferred income | 10,794,486.66 | 11,073,651.66 |
Deferred tax liabilities | 5,463,483.83 | 6,825,450.77 |
Other non-current liabilities | 136,603,881.90 | 136,396,292.55 |
Total non-current liabilities | 402,428,741.25 | 413,294,899.15 |
Total Liabilities | 2,817,464,808.20 | 2,662,581,852.15 |
Equity: | ||
Share capital | 1,240,978,400.00 | 1,241,106,400.00 |
Other equity instruments | ||
Including: Preference Shares | ||
Perpetual bonds | ||
Capital surplus | 2,954,305,867.27 | 2,947,263,843.53 |
Less: Treasury stock | 309,451,578.83 | 240,255,502.45 |
Other comprehensive income | 35,430,564.25 | 26,512,917.07 |
Special reserve | 15,779,321.40 | 14,488,955.52 |
Surplus reserves | 51,830,974.45 | 51,830,974.45 |
General risk preparation | ||
Retained earnings | 107,992,065.03 | 23,018,722.11 |
Total equity attributable to owners of the parent | 4,096,865,613.57 | 4,063,966,310.23 |
Non-controlling interests | 213,457,536.58 | 202,028,952.72 |
Total equity | 4,310,323,150.15 | 4,265,995,262.95 |
Total liabilities and equity | 7,127,787,958.35 | 6,928,577,115.10 |
Legal representative: Tang Zhuolin, Chief Financial Officer: Shao Yongfeng, Person-in-charge of the accounting organ: Yao Bin
(2) Consolidated Income Statement for Q1 2023
Unit: RMB
Item | Q1 2023 | Q1 2022 |
1 Total operating revenue | 907,101,141.80 | 636,006,580.11 |
Including: Operating revenue | 907,101,141.80 | 636,006,580.11 |
Interest income | ||
Premiums earned | ||
Fee and commission income | ||
2 Total operating cost | 816,570,578.44 | 576,816,779.91 |
Including: Cost of sales | 653,454,327.84 | 472,346,527.10 |
Interest expense | ||
Payment of fees and commission | ||
Surrender fund | ||
Net indemnity expenditure | ||
Draw the net reserve of insurance |
Item | Q1 2023 | Q1 2022 |
liability contract | ||
Policy dividend expense | ||
Reinsurance cost | ||
Taxes and surcharges | 4,693,860.22 | 4,022,255.53 |
Selling expenses | 49,395,917.66 | 24,373,541.29 |
Administrative expenses | 76,467,070.01 | 62,766,418.15 |
R&D expenses | 27,637,218.09 | 18,824,950.19 |
Finance costs | 4,922,184.62 | -5,516,912.35 |
Including: Interest expenses | 2,869,618.96 | 4,443,668.86 |
Interest income | 6,504,802.55 | 5,483,896.31 |
Add: Other income | 2,550,704.06 | 3,455,142.45 |
Investment income (loss with "-" sign) | 11,843,626.19 | -4,249,447.63 |
Including: Share of profit or loss of joint ventures and associates | -1,617,104.92 | 44,614.18 |
Income from derecognition of financial assets measured at amortized cost (loss with "-" sign) | ||
Exchange gain (loss with "-" sign) | ||
Net exposure hedging gain (loss with "-" sign) | ||
Gain/loss on changes in fair value (loss with "-" sign) | 18,689,791.21 | -8,257,489.80 |
Credit impairment loss (loss is listed with "-" sign) | -410,038.39 | 4,297,826.65 |
Asset impairment loss (loss with "-" sign) | -1,438,574.33 | -634,508.31 |
Gain/loss on disposal of assets (loss with "-" sign) | -382,067.42 | |
3 Operating profit (losses are listed with "-" sign) | 121,384,004.68 | 53,801,323.56 |
Add: Non-operating income | 876,053.60 | 238,187.76 |
Less: Non-operating expenses | 882,910.87 | 81,446.72 |
5 Gross profit (the gross loss shall be filled in with the sign "-") | 121,377,147.41 | 53,958,064.60 |
Less: Income tax expenses | 24,873,932.20 | 12,707,811.73 |
Net profit (net loss is listed with "-" sign) | 96,503,215.21 | 41,250,252.87 |
(1) Net profit from continuing operations | ||
i. Net profit from continuing operations (net loss with "-" sign) | 96,503,215.21 | 41,250,252.87 |
ii. Net profit from termination of operation (net loss with "-" sign) | ||
(2) Net profit classified by attribution of ownership | ||
i. Net profit attributable to owners of the parent | 84,973,342.92 | 37,109,411.15 |
Item | Q1 2023 | Q1 2022 |
ii. Net profit attributable to non-controlling interests | 11,529,872.29 | 4,140,841.72 |
6 Other comprehensive income/(loss), net of tax | 8,816,358.75 | -12,147,447.87 |
Other comprehensive income/(loss) attributable to owners of the parent, net of tax | 8,917,647.18 | -11,336,050.09 |
(1) Other comprehensive loss that will not be reclassified to profit or loss | -229,036.89 | 267,186.98 |
i. Changes caused by remeasurements on defined benefit schemes | -229,036.89 | 267,186.98 |
ii. Other comprehensive income that cannot be transferred to profit or loss under the equity method | ||
iii. Changes in fair value of investments in other equity instruments | ||
iv. Fair value change of enterprise's own credit risk | ||
v. Other | ||
(2) Other comprehensive income/(loss) that will be reclassified to profit or loss | 9,146,684.07 | -11,603,237.07 |
i. Other comprehensive income that can be transferred to profit or loss under the equity method | ||
ii. Changes in fair value of other debt investments | ||
iii. The amount of financial assets reclassified to other comprehensive income | ||
iv. Provision for credit impairment of other debt investments | ||
v. Cash flow hedging reserve | ||
vi. Differences arising from the translation of foreign currency-denominated financial statements | 9,146,684.07 | -11,603,237.07 |
vii. Other | ||
Other comprehensive income attributable to non-controlling interests, net of tax | -101,288.43 | -811,397.78 |
Total comprehensive income | 105,319,573.96 | 29,102,805.00 |
Total comprehensive income attributable to owners of the parent | 93,890,990.10 | 25,773,361.06 |
Total comprehensive income attributable to non-controlling interests | 11,428,583.86 | 3,329,443.94 |
Earnings per share: | ||
(1) Basic earnings per share | 0.07 | 0.03 |
(2) Diluted earnings per share | 0.07 | 0.03 |
Legal representative: Tang Zhuolin, Chief Financial Officer: Shao Yongfeng, Person-in-charge of the accounting organ: Yao Bin
(3) Consolidated Statement of Cash Flows for Q1 2023
Unit: RMB
Item | Q1 2023 | Q1 2022 |
1 Cash flows from operating activities: | ||
Proceeds from sale of goods and rendering of services | 1,133,116,009.63 | 928,486,238.07 |
Net increase in customer deposits and interbank deposits | ||
Net increase in borrowing from the central bank | ||
Net increase in funds transferred to other financial institutions | ||
Cash received from the premium of the original insurance contract | ||
Net cash received from reinsurance business | ||
Net increase in depositors' deposits and investment funds | ||
Cash that collects interest, commission and commission | ||
Net increase in borrowed funds | ||
Net increase in funds for repurchase business | ||
Net cash received by agents buying and selling securities | ||
Receipts of taxes and surcharges refunds | 12,654,705.82 | 15,645,068.29 |
Cash generated from other operating activities | 17,909,137.78 | 22,607,109.83 |
Subtotal of cash generated from operating activities | 1,163,679,853.23 | 966,738,416.19 |
Payments for goods and services | 801,773,222.77 | 630,966,598.83 |
Net increase in customer loans and advances | ||
Net increase in central bank and interbank deposits | ||
Cash to pay the indemnity of the original insurance contract | ||
Net increase in loan funds | ||
Cash for the payment of interest, fees and commissions | ||
Cash for the payment of policy dividends | ||
Cash payments to and on behalf of employees | 147,283,122.05 | 103,051,894.89 |
Payments of all types of taxes and surcharges | 24,101,285.42 | 33,816,513.68 |
Cash used in other operating activities | 86,092,631.69 | 113,380,059.87 |
Subtotal of cash used in operating activities | 1,059,250,261.93 | 881,215,067.27 |
Net cash generated from/used in operating activities | 104,429,591.30 | 85,523,348.92 |
2 Cash flows from investing activities: | ||
Proceeds from disinvestment | 1,057,772,710.37 | 1,357,115,658.04 |
Investment income | 31,580,739.51 | 9,151,644.38 |
Net proceeds from the disposal of fixed assets, intangible assets and other long-lived assets | 1,800.00 | |
Disposal of net cash received by subsidiaries and other business units |
Item | Q1 2023 | Q1 2022 |
Cash generated from other investing activities | ||
Subtotal of cash generated from investing activities | 1,089,355,249.88 | 1,366,267,302.42 |
Payments for the acquisition of fixed assets, intangible assets and other long-lived assets | 31,121,172.19 | 25,429,170.52 |
Payments for investments | 985,477,069.85 | 1,243,551,176.26 |
Net increase in pledged loans | ||
Obtain net cash paid by subsidiaries and other business units | 48,000,000.00 | |
Cash used in other investing activities | 52,140,000.00 | |
Subtotal of cash used in investing activities | 1,016,598,242.04 | 1,369,120,346.78 |
Net cash generated from/used in investing activities | 72,757,007.84 | -2,853,044.36 |
3 Cash flows from financing activities: | ||
Absorb the cash received by the investment | ||
Including: the subsidiary absorbs the cash received from the investment of minority shareholders | ||
Borrowings raised | 76,518,715.93 | 211,775,514.73 |
Cash generated from other financing activities | 66,555,529.72 | 360,325,501.52 |
Subtotal of cash generated from financing activities | 143,074,245.65 | 572,101,016.25 |
Repayment of borrowings | 28,294,072.18 | 239,525,593.46 |
Interest and dividends paid | 1,631,824.74 | 1,883,623.89 |
Including: Interest and dividends paid to minority shareholders | ||
Cash used in other financing activities | 155,318,603.67 | 311,119,429.66 |
Subtotal of cash used in financing activities | 185,244,500.59 | 552,528,647.01 |
Net cash generated from/used in financing activities | -42,170,254.94 | 19,572,369.24 |
4 Effect of foreign exchange rates changes on cash and cash equivalents | 5,507,470.66 | -18,537,842.93 |
5 Net (decrease)/increase in cash and cash equivalents | 140,523,814.86 | 83,704,830.87 |
Add: Cash and cash equivalents, beginning of the period | 1,233,720,697.27 | 1,259,303,775.74 |
6 Cash and cash equivalents, end of the period | 1,374,244,512.13 | 1,343,008,606.61 |
Legal representative: Tang Zhuolin, Chief Financial Officer: Shao Yongfeng, Person-in-charge of the accounting organ: Yao Bin
2. Audit Report
Whether the Report has been audited
□ Yes √ No
The report for the 1
stquarter of 2023 of the Company has not been audited.
Board of Directors
ofGuangdong Dongfang Precision Science & Technology Co., Ltd.
21 April 2023